
    
      Single arm, open-label, multicenter study to evaluate the treatment satisfaction, treatment
      confidence, and subject preference for Sumavel DosePro in adult subjects diagnosed with
      migraines and currently treated with triptans. Subjects will treat up to 4 migraines over a
      60 day period and complete migraine diaries and questionnaires.
    
  